Medicare Enrolled
Dr. Selorm Takyi, MD
Physical Medicine & Rehabilitation · Marlton, NJ
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Takyi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Takyi?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Takyi
Dr. Selorm Takyi is a physical medicine & rehabilitation specialist in Marlton, NJ, with 11 years of NPI registration. Based on federal Medicare data, Dr. Takyi performed 3,914 Medicare services across 907 unique beneficiaries.
Between the years covered by Open Payments, Dr. Takyi received a total of $1,039 from 18 pharmaceutical and/or device companies across 59 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in physical medicine & rehabilitation. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Takyi is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 11 years in practice
▲ Top 20% volume in NJ
$1,039 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,914
Medicare services
Top 20% in NJ for physical medicine & rehabilitation
907
Unique beneficiaries
$94
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~356 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
792 | $102 | $475 |
| Drug screening test A laboratory test that uses a chemistry analyzer to detect the presence of drugs in a sample. |
703 | $61 | $2,056 |
| Definitive drug test using GC/MS or LC/MS A definitive drug test that identifies specific drugs and distinguishes between structural isomers using advanced methods like GC/MS or LC/MS. |
687 | $242 | $3,082 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
556 | $1 | $65 |
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
289 | $0 | $525 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
154 | $0 | $45 |
| Orthovisc intra-articular injection An injection of hyaluronan or its derivative into a joint space to provide lubrication and cushioning. |
135 | $100 | $1,222 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
79 | $63 | $2,200 |
| Fluoroscopic guidance for needle placement Use of real-time X-ray imaging to guide the precise placement of a needle during a medical procedure. |
79 | $23 | $500 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
68 | $70 | $375 |
| Ultrasound-guided large joint aspiration or injection This procedure uses ultrasound imaging to guide the removal of fluid from or the injection of medication into a large joint. |
67 | $97 | $3,490 |
| Injection of anesthetic or steroid into sacroiliac joint with imaging guidance This procedure involves injecting an anesthetic or steroid medication into the joint connecting the lower spine and hip bone. Imaging guidance is used to ensure accurate placement of the injection. |
66 | $195 | $3,467 |
| Trigger point injection, 3 or more muscles Injection of medication into three or more specific muscle trigger points to relieve pain. |
47 | $50 | $620 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
26 | $117 | $650 |
| Spine facet joint injection with imaging guidance, single level An injection is administered into a single facet joint of the lower or sacral spine while using imaging guidance to ensure accurate placement. |
25 | $201 | $5,100 |
| Facet joint injection, second level, with imaging guidance An injection into a lower or sacral spine facet joint using imaging guidance for the second level treated. |
25 | $103 | $3,600 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
22 | $87 | $3,600 |
| Ultrasound guidance for needle placement Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure. |
19 | $45 | $1,100 |
| Definitive drug test using GC/MS or LC/MS A definitive drug test that identifies specific drugs and distinguishes between structural isomers using advanced methods like GC/MS or LC/MS. |
19 | $112 | $2,148 |
| Facet joint nerve destruction, additional joint This procedure uses imaging guidance to destroy nerves in an additional lower or sacral spinal facet joint. |
16 | $304 | $5,912 |
| Injection of anesthetic agent and/or steroid into other nerve or branch | 15 | $63 | $2,000 |
| Facet joint nerve destruction, single joint A procedure to destroy nerves in a single lower or sacral spinal facet joint using imaging guidance to target pain signals. |
14 | $546 | $7,086 |
| Nerve conduction study, 9-10 studies A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function. |
11 | $187 | $3,600 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$1,039
Total received (2019-2024)
Avg $173/year across 6 years
Top 27% in NJ for physical medicine & rehabilitation
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
18
Companies
59
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,039 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$301
2023
$152
2022
$148
2021
$39
2020
$288
2019
$111
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Nalu Medical, Inc.
$135
PROTEGA PHARMACEUTIALS INC
$66
SI-BONE, INC.
$28
Avanos Medical
$20
Collegium Pharmaceutical, Inc.
$18
Bioventus LLC
$18
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$16
Top 3 companies account for 76.1% of 2024 payments
All-time payments by company (2019-2024) ›
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$170
Nalu Medical, Inc.
$135
Collegium Pharmaceutical, Inc.
$102
ARBOR PHARMACEUTICALS, INC.
$100
PROTEGA PHARMACEUTIALS INC
$99
Scilex Pharmaceuticals Inc.
$84
SCILEX PHARMACEUTICALS INC.
$65
Bioventus LLC
$54
Sonex Health, Inc.
$42
Avanos Medical
$33
Kowa Pharmaceuticals America, Inc.
$31
SI-BONE, INC.
$28
PFIZER INC.
$26
SANOFI-AVENTIS U.S. LLC
$15
Pacira Pharmaceuticals Incorporated
$15
Lilly USA, LLC
$14
Abbott Laboratories
$13
DePuy Synthes Sales Inc.
$13
Top 3 companies account for 39.2% of all-time payments
Associated products mentioned in payments ›
Belbuca · DUROLANE · Durolane · EMGALITY · Exparel · Horizant · LYRICA · MONOVISC · Nalu Neurostimulation System · OCTRODE · RELISTOR · ROXYBOND · SEGLENTIS · SYNVISC-ONE · Seglentis · Sx-one Microknife · TRAYS- ALL · TRIVISC SODIUM HYALURONATE · XTAMPZA · ZTLido
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Physical medicine & rehabilitations within 10 mi
302
Per 100K population
65.1
County median income
$105,271
Nearest hospital
WEISMAN CHILDRENS REHABILITATION HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Takyi is a clinical cardiology specialist, with above-average Medicare volume (top 20% in NJ), with low-engagement industry engagement.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Takyi experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Takyi performed 792 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Takyi receive payments from pharmaceutical companies?
Yes. Dr. Takyi received a total of $1,039 from 18 companies across 59 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Takyi's costs compare to other physical medicine & rehabilitations in Marlton?
Dr. Takyi's average Medicare payment per service is $94. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Takyi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Physical Medicine & Rehabilitation
Common procedures, typical costs, and what industry payments mean in physical medicine & rehabilitation.
Same specialty & city
Physical Medicine & Rehabilitations in Marlton
Browse physical medicine & rehabilitations in Marlton ranked by procedure volume and transparency data.
Highest volume
Top Physical Medicine & Rehabilitations in NJ
Physical medicine & rehabilitations ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Physical Medicine & Rehabilitations in NJ
Which NJ physical medicine & rehabilitations receive the most from drug and device companies.
By company
Salix Pharmaceuticals, a division of Bausch Health US, LLC Payments to Doctors
See all physicians who received payments from Salix Pharmaceuticals, a division of Bausch Health US, LLC.
By company
Nalu Medical, Inc. Payments to Doctors
See all physicians who received payments from Nalu Medical, Inc.
By company
Collegium Pharmaceutical, Inc. Payments to Doctors
See all physicians who received payments from Collegium Pharmaceutical, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology